Komori
Governance4888STELLA PHARMA CORPORATIONPharmaceuticals

Independent Officer Notification Form

Effective 24 June 2026, the company plans to designate outside director Machida Misa (町田美紗) as a new independent officer. The 2 existing independent officers will continue to be designated.

Worth reading
33Immaterial
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
1
people (planned increase in the number of independent officers)
Wording
Definitive
How definitive the wording is.

Governance structure

Company with an Audit and Supervisory Committee
Number of independent officers3Number

This is the number of people reported to the exchange as independent officers. Whether someone is an outside officer and whether they qualify as independent are separate determinations.

Changes this time

Effective 24 June 2026, a proposal to elect Machida Misa (町田美紗) as a new outside director will be submitted, and she is scheduled to be designated as an independent officer. Existing independent officers Tsujii Kohei (辻井康平) and Fukuchi Toshiyuki (福地叔之) will continue in their roles.

Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit and Supervisory Committee
Number of independent officers3 people (Tsujii Kohei (辻井 康平), Fukuchi Toshiyuki (福地 叔之), and Machida Misa (町田 美紗))
Changes this timeEffective 24 June 2026, a proposal to elect Machida Misa (町田美紗) as a new outside director will be submitted, and she is scheduled to be designated as an independent officer. Existing independent officers Tsujii Kohei (辻井康平) and Fukuchi Toshiyuki (福地叔之) will continue in their roles.
Items this document does not state (5)
Number of directorsCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because a proposal for the election of outside officers will be submitted to the Annual General Meeting of Shareholders. All outside officers who meet the independence criteria are designated as independent officers.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Independent Officer Notification Form | STELLA PHARMA CORPORATION (4888) timely disclosure | Komori